Independent validation of the Mosamatic deep learning automated skeletal muscle and adipose tissue segmentation tool in an external Chinese cancer patient cohort.

OBJECTIVES

Deep learning neural network (DLNN)-based tools can automate body composition analysis for cancer cachexia research. We aimed to evaluate a DLNN tool trained on a European population of Chinese cancer patients.

METHODS

Computed tomography (CT) images at the 3rd lumbar vertebral (L3) level of Chinese gastric cancer patients were retrospectively collected.

An externally validated DLNN tool (Mosamatic) was used to segment skeletal muscle, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). Manual segmentation was performed using SliceOmatic software (TomoVision, version 5.0).

Geometric similarity between automated and manual segmentation, and the reliability was assessed.

RESULTS

The cohort comprised 203 patients with a median body mass index (BMI) of 22.2 kg/m 2, and 604 CT images at L3 were collected. The median Dice Similarity Coefficient (IQR) of skeletal muscle, VAT and SAT were 0.973 (0.961-0.980), 0.980 (0.964-0.989), and 0.967 (0.945-0.977), respectively.

The median Lin’s Concordance Correlation Coefficient for skeletal muscle area (0.983), VAT area (1.000), SAT area (0.998), skeletal muscle radiation attenuation (0.995), VAT radiation attenuation (0.994), and SAT radiation attenuation (0.997) demonstrated excellent reliability. Low BMI (<18.5 kg/m 2) and ascites impaired the agreement between the 2 methods.

The automated method showed high diagnostic concordance with manual segmentation for sarcopenia (κ = 0.843, P < .001) and myosteatosis (κ = 0.946, P < .001).

CONCLUSIONS

The Mosamatic tool displays excellent generalizability to analyse body compositions in Chinese gastric cancer patients and can facilitate cachexia research.

ADVANCES IN KNOWLEDGE

The Mosamatic tool displayed excellent generalizability without recalibration to analyse body composition on the 3rd lumbar vertebral CT images in Chinese gastric cancer patients.

Sander S Rensen

Biochemistry - Oncology

Maastricht University

Netherlands

452

ScienceLeadR Reputation
profile photo of Sander S Rensen

Main topics

Publications Clinical Trials

Cancer-associated cachexia
Cachexia
Sarcopenia
Weight Loss
MASH
View detailed profile

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!